Last reviewed: July 10, 2026
Last updated: July 10, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Tirzepatide pens like Mounjaro are engineered with a built-in safety mechanism that leaves a small amount of liquid in the cartridge after each injection—typically 0.3 mL or more depending on the dose strength. This residual volume is not a manufacturing defect or wasted medication; it's a deliberate design choice that protects both the needle and ensures accurate dosing across treatment tiers. Knowing what to expect helps patients distinguish between normal operation and potential injection problems.
Why Mounjaro Pens Retain Residual Liquid After Injection
Pharmaceutical manufacturers design tirzepatide pens with internal safety features that prevent the needle from fully emptying the cartridge. The plunger stops before reaching the bottom of the medication chamber, leaving behind a deliberate buffer of liquid. This design protects the delicate needle mechanism from air exposure and prevents the plunger from becoming stuck or damaged during repeated use.
The residual liquid volume remains consistent across all dose levels because it exists in a fixed chamber zone, not as part of the active medication dose. A 2.5 mg dose delivers exactly 2.5 mg of tirzepatide; the remaining liquid serves only mechanical protection. This separation ensures dosing accuracy while maintaining device integrity throughout your treatment course.
Understanding Dose Delivery and Cartridge Depletion
Each time you inject with a Mounjaro pen, the dose counter clicks down and the plunger advances slightly—but stops short of the cartridge's bottom. You'll notice the counter reaches zero before the pen feels completely empty. This is completely normal and indicates your full prescribed dose has been delivered, despite liquid remaining visible inside.
When the cartridge is truly empty and no longer usable, the pen becomes locked—the plunger cannot be pressed further and the dose counter will no longer advance. At this point, you should dispose of the used pen in a sharps container and begin a new one. Attempting to force the plunger or shake out remaining liquid is unnecessary and risks damaging the needle or injector mechanism.
Safe Injection Technique to Minimize Issues
Proper injection technique reduces the risk of incomplete delivery or needle-related problems. Before injecting, hold the pen at a 90-degree angle to your skin, pinch a fold of skin at the injection site, and insert the needle fully. Keep the pen steady against your skin for the full 6-second count while pressing the injection button—rushing through this step can result in incomplete medication delivery.
After the 6-second hold, remove the pen and immediately replace the needle cap. Never reuse needles between injections, as dull needles increase injection difficulty and can compromise the seal. If you feel resistance during injection or suspect the needle is clogged, stop immediately and switch to a fresh needle rather than forcing the plunger, which could damage the internal mechanism.
When to Consider Compounded Tirzepatide Alternatives
Some patients prefer injectable tirzepatide from licensed 503A compounding pharmacies because it offers flexibility in dosing schedules and eliminates concerns about pen mechanisms entirely. PlexusDx provides compounded tirzepatide injection starting at $289/mo (or $249/mo on the 6-month plan) across all dose levels, with the pricing guarantee that your dose may increase but your monthly cost stays the same. Compounded versions deliver the same active medication through traditional syringes and vials, giving you control over dose timing without worrying about residual liquid or counter mechanics.
PlexusDx also offers oral tirzepatide as an alternative for patients who prefer tablets, available at $349 per month. Both options bypass injectable pen limitations entirely while maintaining the same GLP-1 receptor agonist and GIP receptor agonist activity that makes tirzepatide effective for weight loss and metabolic health. HSA and FSA accounts cover both compounded and oral formulations, and no insurance or membership is required to access treatment across all 50 states.
The Role of Genetic Testing in Optimizing Your Therapy
The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761), and GIPR (rs1800437) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
Understanding your genetic peptide profile reduces trial-and-error dosing and allows earlier shifts to alternative compounds if needed. Patients with certain genetic signatures may find oral formulations or dual-compound options (like GLP-Squared) more effective than traditional tirzepatide alone. The Precision Peptide Genetic Test is available as a $99 add-on after your first month of treatment, making personalization accessible without delaying your weight loss journey.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $289/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is the leftover liquid in my Mounjaro pen wasted medication?
No. The residual liquid is a safety mechanism that protects the needle and pen mechanics. Your full prescribed dose was delivered when the counter reached zero. The remaining liquid serves only to prevent damage to the internal components.
What should I do if my Mounjaro pen feels stuck or won't inject?
Stop immediately and replace the needle with a new one. A clogged needle can indicate debris, improper storage temperature, or needle damage. Never force the plunger, as this may damage the injection mechanism. If a fresh needle doesn't resolve the issue, contact your prescriber about switching to a new pen.
How does compounded tirzepatide from PlexusDx differ from Mounjaro pens?
PlexusDx compounded tirzepatide injection delivers the same active medication through traditional syringes and vials from licensed 503A compounding pharmacies. It eliminates pen mechanics, offers flexible dosing schedules, and costs $249 per month flat regardless of dose level. No insurance is required, and treatment is available in all 50 states.
Can I switch between Mounjaro pens and compounded tirzepatide without side effects?
Both deliver identical tirzepatide molecules and should not cause additional side effects during transition. Your prescriber can guide the switch timing to maintain consistent dosing. Many patients transition to compounded options to simplify administration or address supply concerns.
How can genetic testing help me choose between tirzepatide and other GLP-1 medications?
No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R, and GIPR) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Is Ozempic Meant for Weight Loss? Understanding Its Role and Effectiveness
Can You Take Metformin with Mounjaro? What You Need to Know